Keyphrases
Central Nervous System
100%
Prostate Radiotherapy
100%
Treatment Impact
100%
System Function
100%
Cognitive Function
100%
Androgen Deprivation Therapy
100%
Androgen Receptor Antagonist
66%
Prostate Cancer
33%
Central Nervous System Effects
33%
Blood-brain Barrier Penetration
33%
Enzalutamide
33%
Clinical Trials
16%
Test Instrument
16%
Disease Course
16%
Clinical Setting
16%
Prospective Longitudinal Study
16%
Tolerability
16%
Therapy Options
16%
Adverse Events
16%
Systems Change
16%
Cognitive Assessment
16%
Cognitive Disorders
16%
Ongoing Clinical Trials
16%
Follow-up Interval
16%
Inhibitor Activity
16%
Systemic Therapy
16%
MEDLINE
16%
Accurate Assessment
16%
Androgen Signaling
16%
Extant Data
16%
Darolutamide
16%
Cognitive Effects
16%
Adverse Events Profile
16%
Abiraterone Acetate
16%
Pathway-targeted Therapy
16%
Apalutamide
16%
Drug Safety Profile
16%
Cognitive Management
16%
Neuroscience
Central Nervous System
100%
Androgen
100%
Cognitive Function
100%
Androgen Receptor
57%
Blood Brain Barrier
28%
Enzalutamide
28%
Cognitive Disorders
14%
Cognitive Effect
14%
Vertebral Column
14%
Longitudinal Study
14%
Receptor Antagonist
14%
Abiraterone Acetate
14%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen
100%
Androgen Receptor
42%
Enzalutamide
28%
Clinical Trial
28%
Adverse Event
28%
Blood-Brain Barrier
28%
Tolerability
14%
Clinical Study
14%
Drug Safety
14%
Cognitive Defect
14%
Disease Course
14%
Darolutamide
14%
Androgen Receptor Antagonist
14%
Abiraterone Acetate
14%
Apalutamide
14%